Meeting
2024 ASCO Genitourinary Cancers Symposium
Association of ARID1A deficiency with invasive transformation in metastatic bladder cancer.
Authors
Vincent D'Andrea
Brigham and Women's Hospital, Boston, MA
Vincent D'Andrea , Timothy Hanlon , Rea Chroneos , Raie Bekele , Timothy Clinton , Filipe L.F. Carvalho , Kent William Mouw
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 656)
DOI
10.1200/JCO.2024.42.4_suppl.656
Abstract #
656
Poster Bd #
J20
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Defining the genetic evolution of epigenetic alterations in bladder cancer.
First Author: Timothy Nguyen Clinton
Poster
2017 ASCO Annual Meeting
Activity of RX-3117, an oral antimetabolite nucleoside, in subjects with metastatic bladder cancer resistant to gemcitabine: Preliminary results of a phase Ia/IIb study.
First Author: Jun Gong
Poster
2017 Genitourinary Cancers Symposium
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
First Author: Werner J. Struss
Poster
2024 ASCO Breakthrough
Differences in the expression heterogeneity of ADC-related markers between primary tumors and metastatic lymph nodes in advanced urothelial cancers.
First Author: Xingliang Tan